Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Total Current Liabilities (2019 - 2025)

Silo Pharma's Total Current Liabilities history spans 7 years, with the latest figure at $708339.0 for Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 32.21% year-over-year to $708339.0; the TTM value through Sep 2025 reached $708339.0, down 32.21%, while the annual FY2024 figure was $1.7 million, 113.51% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $708339.0 at Silo Pharma, down from $1.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.7 million in Q4 2024 and bottomed at $264135.0 in Q2 2021.
  • The 5-year median for Total Current Liabilities is $708339.0 (2025), against an average of $727500.5.
  • The largest annual shift saw Total Current Liabilities soared 316.67% in 2023 before it crashed 32.21% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $490039.0 in 2021, then decreased by 10.96% to $436318.0 in 2022, then skyrocketed by 77.76% to $775590.0 in 2023, then soared by 113.51% to $1.7 million in 2024, then tumbled by 57.23% to $708339.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Total Current Liabilities are $708339.0 (Q3 2025), $1.0 million (Q2 2025), and $1.2 million (Q1 2025).